Changes in the NPS market in Eastern and Central Europe

Similar documents
The Polish legislation on smart shops

Annual report 2012: the state of the drugs problem in Europe

Workshop summary. Exchange on data collection challenges related to new psychoactive substances use. Presentation of the situation

NPS use, harms and health responses to NPS in Europe: findings form multi-method studies

Fentanils in Europe: perspective from the EU EWS

Results from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS)

The European Early-warning system on new drugs. Dr. R. Sedefov & D. Lopez, Ancona, 18 September 2009

Youth attitudes on drugs. Analytical report

What is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund

Trends in injecting drug use in Europe

Rapporteur report of Session 2: New Trends in TDI clients. Thursday, September 20th 2012, ( Room 106) Chair: Dragica Katalinic

Improving our capacity of identification and reporting on emerging trends. New methods and new areas of analysis

New trends in harm reduction in Europe: progress made challenges ahead

YOUNG PEOPLE AND DRUGS

Click for Support REALized

Conventional and emerging drugs of abuse: the current situation

Background and Effects of the German New Psychoactive Substances Act

Young people and drugs. Analytical report

about methodology of monitoring and selecting the web shops see methodology on trend.eu/).

Substance briefing: MPPP

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Italy Italy Drug Report 2018

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015

Estonia Estonia Drug Report 2018

FACT SHEET. A selection of internet-based information. Methedrone (bk-pmma)

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

Injection of new psychoactive drugs in Romania multi-indicator analysis

NPS users attitude, behaviours and recommendation for response

EWS in the Czech Republic country example

Finland Finland Drug Report 2018

Annual report 2009: the state of the drugs problem in Europe

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

Hungary Hungary Drug Report 2018

EMCDDA trend report for the evaluation of the EU drugs strategy

New psychoactive substances in Belgium: current status

Poland 9.8 % Country Drug Report 2017 ( ) THE DRUG PROBLEM IN POLAND AT A GLANCE

NPS New Psychoactive Substances

Attitudes, Awareness and Understanding

Cannabis policies & cannabis use

Most recent data, analyses and feed-back from the 2016 DRID national updates

Drug laws, penalties and alternatives across Europe

Belgium 10.1 % Country Drug Report 2017 THE DRUG PROBLEM IN BELGIUM AT A GLANCE

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

New patterns of drug use in Hungary

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Bulgaria Bulgaria Drug Report 2018

2012 NATIONAL REPORT (2011 data) TO THE EMCDDA by the Reitox National Focal Point

2008 EUROBAROMETER SURVEY ON TOBACCO

Slovakia Slovakia Drug Report 2018

Lithuania Lithuania Drug Report 2018

Germany Germany Drug Report 2018

Preparatory study for an Impact Assessment on a new instrument replacing Council Decision 2005/387/JHA on new psychoactive substances

New Psychoactive Substances: The Irish Experience. Tim Murphy Service Manager Cavan and Monaghan Drug and Alcohol Services

Substance briefing: MDPPP

Czech web shop analysis did not find any web shop advertised branded products as containing MDPBP substance.

Cyprus Cyprus Drug Report 2018

The issues facing Europe

EMBARGOED NOT FOR RELEASE PRIOR TO AM WEDNESDAY OCTOBER

Lima - Peru, August 18-22, 2014

Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective

Luxembourg Luxembourg Drug Report 2018

Lithauania 5.1 % Country Drug Report 2017 THE DRUG PROBLEM IN LITHUANIA AT A GLANCE

Developing a drug monitoring system for New Zealand: IDMS

The UNODC Early Warning Advisory On NPS 2 nd Annual Meeting Copolad II

The evolution of the HIV/AIDS outbreak among IDUs in Romania

The Challenge of New Psychoactive Substances (NPS) A Presentation for CAD by Dr Des Corrigan October 2015

Yukon s Proposed Framework for. Legalized Cannabis 30 GRAMS MINIMUM AGE

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Crime and Justice. New Psychoactive Substances Evidence Review

NPS use in Norway. Presented by Ellen J. Amundsen, Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health/ NIPH

Models of good practice in drug treatment in Europe. Project group

Belgium Belgium Drug Report 2018

Acute Drug Toxicity Data

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

Methadone Diversion: Why it happens, what the illicit market looks like and the implications

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID



59 th Session of Commission on Narcotic Drugs Vienna 14-22March 2016

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)

The drugs situation in Ireland: an overview of trends from 2005 to 2015.

Criminal Justice (Psychoactive Substances) Bill Regulatory Impact Analysis

LIMITE EN COUNCIL OF THE EUROPEAN UNION. Brussels, 7 July /11 LIMITE ENFOPOL 228 DAPIX 81

What are they? Why do people take these drugs?


Cyprus Focal Point Report 2014

Austria Austria Drug Report 2018

A new Ballad of East and West Market Monitoring based on Drug Checking in two cities in Austria

Malta Malta Drug Report 2018

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Conflict of Interest Disclosure

Substances under Surveillance

Global drug trends and sustainable development

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot

Proposal for a COUNCIL IMPLEMENTING DECISION

The Netherlands Drug Situation Summary

Transcription:

Changes in the NPS market in Eastern and Central Europe ESSD 27th Annual Conference Frankfurt, 22-24 September 2016 Agnese Zile-Veisberga Artur Malczewski

Outline Methodology; Description of the NPS market in countries; Description of the responses; Effects of the responses.

Aim, methodology Aim: The main objective is to explain and compare the effect on the NPS market brought by new and innovative responses in the EE, LV, LT, PL, HU, CZ, RO. Methodology: A review of available literature covering the NPS market; An analysis of legal acts regulating NPS; A review of situation on the NPS issue; Interviews with experts; Collection and analyses of available data, e.g., seizure data, hospital emergencies, surveys and studies on prevalence

The NPS market The product - substances Distribution: place, legal vs. illegal, online vs. street; price, marketing strategies, distributors profile User s profile: age, gender, occupation, etc.

Substances in 2015 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% EE LV LT PL cannabinoids cathinones phenethylamines opioids arylalkylamines benzodiazepines piperazines Piperidines & pyrrolidines tryptamines other Huge difference between the number of identified NPS in PL more than 17 000, in RO 15 samples (2015) In CZ, RO tested less than 100 samples. In HU mainly in biological samples. When market legal it is more dynamic and substances are changing more often. The most common substances different in each country Source: EWS Final Reports 2015

Situation in countries HU Mainly online distribution Cathinones, cannabinoids 68 % NSP clients in 2014, mainly cathinones Cannabinoids - 7,7% (2013, GPS); 3.8% other NPS (2013, GPS) PL Brick and mortar shops, online distribution Cathinones; cannabinoids 10% 15-16 y.o. (2015, ESPAD); 36% NSP clients (2014); 1.3% general population (2015) LV Brick and mortar shops until 2014 Cannabinoids 13% 15-16 y.o. (2013, ESPAD methodology); 18% party-goers (2012); 3% (2015, GPS)

Situation in countries RO CZ Brick and mortar shops until 2012 Cathinones 9.4% PWID Bucharest as the primary drug (2013) Brick and mortar shops until 2011 Cathinones - 11% NSP clients (2013) EE No data on prevalence and intoxications No shops LT Online shops 3% used NPS (Omnibus survey, 2013)

Legislative responses EE LV LT PL CZ Scheduling with a decree of the minister, special NPS list Scheduling, generic system, temporary ban that entails criminal liability (rapid procedure) Rapid scheduling, generic system Scheduling, immediate removal from the market, large fines Scheduling, since 2015 procedure faster HU Scheduling, a special list of substances under temporary ban / risk assement RO Scheduling, immediate removal of products from the market, criminal liability

Legislative responses More attention when problem is visible brick and mortar shops (LV, PL, RO); In countries where NPS problem not so visible (e.g., no brick and mortar shops) substances scheduled, additional rapid control measures not introduced (EE, LT); In countries where NPS problem considerable, response more sophisticated. To close brick and mortar shops rapid and proactive response with harsh sanctions has worked LV, RO. Simple fines don t work (PL); Important factor in developing legislation has been the negative public opinion, a presure to schedule rapidly and punish distributors harshly.

Online distribution Rapid and proactive legislation with harsh sanctions contribute also to changes in local online distribution no more surface webpages, instead hidden chanels, darknets, foreign domains. In countries with unregulated substances, internet selling active.

Effects of the responses In LV and PL when measures came into force, a number of intoxication increased. Aggresiver marketing and experimenting with NPS. No data from CZ, RO and HU. 2500 Poland 2000 1966 Latvia 1500 95 1000 500 526 510 603 539 661 449 461 528 82 0 52 42 49 34 New substances scheduled Sources: Burda. P, 2014 and 2015; Sīle, 2015, ; January February March April May June Temporary ban entails criminal liability

Effects: legal and illegal market By the end of 2015 the legal market closed in RO and LV When brick and mortar shops are closed availability of substances reduced Reduced NPS market might transfer to the illegal market (LV), but only in cases when legal market not possible. If legal market still possible, used substances will be replaced by new ones; Qualitative changes in the illegal market also possible. Example of heroin shortage initially replaced by cathinones (HU, PL, RO). After closure of the legal market in RO users returned to heroin; in PL continued to use illegal and legal cathinones; in LV even though the legal market was closed, users switch to the illegal carfentanil.

Effects: intoxications and prevalence In RO and LV a number of intoxications decreased after the closure of the NPS legal market. Partially could be associated with experimenting not the regular use, which is why no indications that use of other substances increased; Difficult to assess prevalence data, longer period necessary. However, for example in CZ and RO LTP among clients of NSP considerably decreased.

Prevalence of NPS in general population and sub-populations, 2008-2015 (%) 40 35 36 30 25 20 15 10 12 10,5 10 5 5,2 3,5 3 1,4 1,3 0 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 ESPAD (students 15-16 years old) LTP GPS (15-64years old ) LTP CBOS i KBPN Youth survey(students 18-19 years old) LTP Survey among needles and syringes clients (LMP, mefedron) Sources: ESPAD: (Sierosławski J, 2015, s. 18), GPS (Malczewski A., Misiurek A., 2015, p. 34), Youth Survey: (Malczewski A., 2015, p. 170), Survey among needles and syringes clients: (Malczewski A., 2016, p.25)

Life-time prevalence of NPS in general population and subpopulations, 2011-2014 (%) 40 35 30 25 32 38 ESPAD (15-16 years old) Eurobarometer (15-16 years old) Party-goers 20 15 10 18 18 13 11 9 9 10 GPS (15-64 years old) Inmates 5 3 3 0 2010 2011 2012 2013 2014 2015 2016 Drug users cohort study (Q: Have you ever bought NPS) Sources:: ESPAD (LaSPAD, 2011, p. 66; Trapencieris M. et al., 2013. p. 20); Eurobarometer (European Commission, 2011, p. 19; European Commission, 2014, p. 10); Party-goers (Koroļeva I. et al., 2012, p. 75); GPS - General Population Survey (Sniķere S. et al., 2011, p. 72); Prisons (Kļave E. et al., 2014, p. 35); Drug users cohort study (Trapencieris M. et al., 2014, p. 29).

Effects: changes in attitudes towards NPS and illicit drugs (example of Latvia) The peak of the negative public opinion about NPS was reached in 2014. In 2014, 63% (38% in 2011) agreed that NPS should be banned at any circumstances (Eurobarometer, 2014). The first position among other EU member states. In 2014, 73% agreed that cannabis should be banned, in 2011 64% (Eurobarometer 2011; 2014); In 2015, 88% respondents of a local omnibus survey stated that cannabis shouldn t be legalised, in 2016 83% (the same level in 2012).

Conclusions NPS market in each country is different; Legislative response to the problem different in each country; Seems that harsh sanctions can close brick and mortar shops, consequently also reduce availability; NPS market development after response different as well. By the end of 2015 NPS brick and mortar stores closed in CZ, LV, RO but, in PL operating again. In HU developed online market. Too early to draw conclusion on prevalence of use in wider population. Spread of NPS can bring negative public opinion request to ban everything, also more negative attitudes towards legalisation of other illicit drugs such as cannabis..

Thank you! Agnese.veisberga@iem.gov.lv